Glenn R Larsen Net Worth & Insider Trades

Glenn R Larsen - Director, Anika Therapeutics, Inc

As of June 16, 2023

What is Glenn R Larsen's Net Worth?

The current estimated net worth of Anika Therapeutics, Inc's Director, Glenn R Larsen, is estimated to be about $563.68K . Glenn R Larsen owns about 7,590 units of Anika Therapeutics, Inc common stock. In the last 4 years at Anika Therapeutics, Inc, Glenn R Larsen has sold an estimated value of $249.15K worth.

What is Glenn R Larsen's Past Insider Trading?

Glenn R Larsen's largest sale order was 4,355 units , worth over $249.15K on August 30, 2019. In total, Glenn R Larsen has made about 6 transactions over 4 years of their time at Anika Therapeutics, Inc. Glenn R Larsen usually trades in June, with the busiest year in 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Glenn R Larsen

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Glenn R Larsen's' Mailing Address?

  • Mailing address is 32 Wiggins Avenue Bedford MA 01730 MA

Anika Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Total
Cheryl R. Blanchard, Ph.D. 2020 $548,077 $458,510 $5,335,439 $3,659,450 $27,958 $10,029,434
Michael L. Levitz 2020 $173,077 $73,601 $799,971 $799,993 $11,318 $1,857,960
David Colleran 2020 $344,077 $143,931 $645,900 $553,445 $18,263 $1,705,616
Thomas Finnerty 2020 $353,505 $143,169 $626,367 - $20,746 $1,143,787
James Loerop 2020 $381,563 $171,703 $464,449 - $22,156 $1,039,871
Joseph G. Darling 2020 $80,752 - - - $208,001 $288,753
Sylvia Cheung 2020 $294,252 - $924,637 - $89,644 $1,308,534
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/898437/000117184321002976/def14a_042921.htm

What are Anika Therapeutics, Inc's Past Insider Trades?

Anika Therapeutics, Inc's most recent insider trade came on May 12, 2022 by David Colleran who bought 1,500 units worth $32.05K . In the last 18 years, insiders at Anika Therapeutics, Inc have sold an estimated value of $67.54M and bought an estimated value of $5.82M worth of shares. Insider trading is most common in February, with the busiest year in 2017 and 2006. The most active traders at the company are Charles H Sherwood, CEO and Director,  Steve Wheeler, Director,  and Joseph L Bower, Director .

Anika Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...